Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Land and Mineral Rights
QFR217385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
4,946.00
Year-over-Year Change
1.04%
Date Range
10/1/2000 - 1/1/2025
Summary
This trend tracks the financial reporting of land and mineral rights within the U.S. pharmaceutical and medicines sector. It provides critical insights into corporate asset valuation and strategic resource management in a key industry segment.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The data represents the quarterly financial accounting of land and mineral rights held by pharmaceutical corporations, reflecting potential long-term investment strategies and asset portfolio compositions. Economists analyze this metric to understand corporate resource allocation and potential future development capabilities.
Methodology
Data is collected through mandatory quarterly financial reporting by publicly traded pharmaceutical corporations, compiled and standardized by federal economic research agencies.
Historical Context
This trend is used in macroeconomic analysis to assess corporate asset strategies, potential resource development, and sector-specific investment patterns.
Key Facts
- Tracks quarterly land and mineral rights for pharmaceutical corporations
- Provides insights into corporate resource management strategies
- Part of comprehensive financial reporting for publicly traded companies
FAQs
Q: What does this economic trend measure?
A: It measures the financial reporting of land and mineral rights within the U.S. pharmaceutical and medicines sector, tracking corporate asset holdings.
Q: Why are land and mineral rights important for pharmaceutical companies?
A: These rights can represent potential future research facilities, resource development sites, or strategic long-term investments for pharmaceutical corporations.
Q: How often is this data updated?
A: The data is updated quarterly, providing a consistent snapshot of corporate asset management in the pharmaceutical sector.
Q: How do economists use this trend?
A: Economists analyze this trend to understand corporate investment strategies, sector-specific resource allocation, and potential future development capabilities.
Q: What are the limitations of this data?
A: The data only covers publicly traded pharmaceutical corporations and represents a specific moment in time, which may not reflect entire industry dynamics.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Motor Vehicles and Parts: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301376USNO
Quarterly Financial Report: U.S. Corporations: All Other Retail Trade: Total Cash on Hand and in U.S. Banks
QFRTCASHOTRUSNO
Quarterly Financial Report: U.S. Corporations: Furniture and Related Products: Net Sales, Receipts, and Operating Revenues
QFR101337USNO
Quarterly Financial Report: U.S. Corporations: Scientific Research and Development Services: Long-Term Debt, Due in More Than 1 Year: Loans from Banks
QFR316547USNO
Quarterly Financial Report: U.S. Corporations: All Professional and Technical Services, Except Legal Services: Capital Stock and Other Capital (Less Treasury Stock)
QFRD326PTSUSNO
Quarterly Financial Report: U.S. Corporations: All Nondurable Manufacturing: Cash Dividends Charged to Retained Earnings This Quarter
QFR120NDUUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Land and Mineral Rights [QFR217385USNO], retrieved from FRED.
Last Checked: 8/1/2025